• 1. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143

Introduction to 1,3-Benzenedicarboxylic acid, 4-fluoro-, 3-methyl ester (CAS No. 41684-09-7) in Modern Chemical and Pharmaceutical Research

1,3-Benzenedicarboxylic acid, 4-fluoro-, 3-methyl ester, identified by the chemical identifier CAS No. 41684-09-7, is a fluorinated aromatic dicarboxylic acid ester that has garnered significant attention in the realm of chemical and pharmaceutical research. This compound, characterized by its structural motif of a benzene ring substituted with a fluoro group at the fourth position and a methyl ester at the third position, exhibits unique chemical properties that make it a valuable intermediate in the synthesis of various biologically active molecules.

The relevance of 1,3-benzenedicarboxylic acid, 4-fluoro-, 3-methyl ester stems from its versatility in medicinal chemistry. The presence of both fluoro and ester functional groups imparts distinct electronic and steric properties to the molecule, which can be leveraged to modulate its interactions with biological targets. Specifically, the fluoro group is known to enhance metabolic stability and binding affinity, while the ester moiety provides a handle for further derivatization via hydrolysis or transesterification reactions.

In recent years, the pharmaceutical industry has increasingly recognized the importance of fluorinated compounds in drug development. Fluorine atoms can influence multiple pharmacokinetic properties of a drug molecule, including its solubility, bioavailability, and metabolic clearance. The incorporation of fluorine into drug candidates often leads to improved pharmacological profiles, making compounds like 1,3-benzenedicarboxylic acid, 4-fluoro-, 3-methyl ester particularly attractive for medicinal chemists.

One of the most compelling applications of 1,3-benzenedicarboxylic acid, 4-fluoro-, 3-methyl ester is in the synthesis of fluorinated heterocycles, which are prevalent in many modern therapeutic agents. Heterocyclic compounds form the backbone of numerous drugs due to their ability to mimic natural biomolecules and interact with biological receptors in a highly specific manner. The structural features of 1,3-benzenedicarboxylic acid, 4-fluoro-, 3-methyl ester make it an ideal precursor for constructing such heterocycles through cyclization reactions.

Recent advancements in synthetic methodologies have further highlighted the utility of this compound. For instance, transition-metal-catalyzed cross-coupling reactions have enabled efficient functionalization of the aromatic ring at both the fluoro and methyl ester positions. These techniques have opened up new avenues for generating structurally diverse derivatives with tailored biological activities. Such methodologies are particularly valuable in fragment-based drug discovery programs, where small molecular building blocks like 1,3-benzenedicarboxylic acid, 4-fluoro-, 3-methyl ester are used to identify lead compounds through high-throughput screening.

The role of computational chemistry in optimizing synthetic routes for 1,3-benzenedicarboxylic acid, 4-fluoro-, 3-methyl ester cannot be overstated. Molecular modeling techniques have been instrumental in predicting reaction outcomes and identifying optimal conditions for its synthesis. By leveraging quantum mechanical calculations and machine learning algorithms, researchers can accelerate the discovery process and minimize experimental trial-and-error. This approach aligns well with contemporary trends toward green chemistry and sustainable drug manufacturing practices.

From a biological perspective,1,3-benzenedicarboxylic acid, particularly its fluorinated derivatives, exhibits potential as an intermediate in the development of novel therapeutic agents targeting various diseases. For example, studies have demonstrated that fluorinated benzoic acid derivatives can modulate enzyme activity and receptor binding affinity, making them promising candidates for treating neurological disorders, cancer, and inflammatory conditions. The specific substitution pattern present in 1,3-benzenedicarboxylic acid, 4-fluoro, -, 3-methyl ester (CAS No. 41684-09-7) may confer unique pharmacological properties that could be exploited for therapeutic intervention.

The synthesis of 1,3-benzenedicarboxylic acid, -,-fluoro, -,-methyl ester involves multi-step organic transformations that highlight its synthetic versatility. Key steps typically include fluorination reactions to introduce the fluoro group at the fourth position followed by esterification to attach the methyl group at the third position. Advanced synthetic strategies may also incorporate protective group strategies to ensure regioselective functionalization without unwanted side reactions.

In conclusion,1,3-benzenedicarboxylic acid, -,-fluoro, -,-methyl ester (CAS No. 41684-09-7) represents a fascinating compound with significant potential in pharmaceutical research. Its unique structural features make it a valuable building block for designing biologically active molecules with enhanced pharmacological properties. As synthetic methodologies continue to evolve, this compound will undoubtedly play an increasingly important role in drug discovery efforts aimed at addressing unmet medical needs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)